血液透析機/腹膜透析市場規模、佔有率和成長分析（按類型、產品、最終用途和地區）：產業預測（2024-2031）

2022年全球血液透析機/腹膜透析市場規模將為811.1億美元，從2023年的863.8億美元擴大到2031年的1429.7億美元，並將在預測期內（2024-2031年）成長。成長率為6.5%）。

由於器官捐贈者短缺、急性腎損傷盛行率上升以及器官移植相關風險，全球血液透析機和腹膜透析市場正經歷顯著成長。此外，大公司的技術進步和創新正在刺激新產品和服務的開發。慢性腎臟病（CKD）通常會導致末期腎功能衰竭（ESRD），是該市場的主要需求促進因素，因為腎功能下降與糖尿病和高血壓等疾病有關。特別是，由於老化、肥胖和不良生活習慣導致糖尿病盛行率不斷上升，導致糖尿病腎臟病和腎臟損害，進一步加速了全球對透析治療的需求。

目錄

介紹

• 分析目的
• 定義
• 市場範圍

分析方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況及展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 監管環境
• 價值鏈分析
• 供應鏈分析
• 技術分析
• 專利分析
• 價格分析
• 貿易分析
• 客戶和購買標準分析

血液透析機/腹膜透析市場：依類型

• 市場概況
• 血液透析機
  • 傳統的
  • 短期透析
  • 夜間血液透析機
• 腹膜透析
  • 連續性攜帶式腹膜透析（CAPD）
  • 自動腹膜透析（APD）

血液透析機/腹膜透析市場：依產品

• 市場概況
• 裝置
  • 機器
  • 透析設備
  • 水處理系統
  • 其他
• 消耗品
  • 血統
  • 集中
  • 導管
  • 其他
• 服務

血液透析機/腹膜透析市場：依最終用途

• 市場概況
• 以家庭為基礎
• 以醫院為基礎

血液透析機/腹膜透析市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲 (MEA)
  • 波灣合作理事會(GCC) 國家
  • 南非
  • 其他中東/非洲

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• 費森尤斯醫療保健股份公司（德國）
• 巴克斯特（美國）
• 達維塔公司（美國）
• 日機裝株式會社（日本）
• 貝朗公司（德國）
• 美敦力（美國）
• 旭化成株式會社（日本）
• 泰爾茂株式會社（日本）
• 東麗醫療株式會社（日本）
• 尼普羅株式會社（日本）
• Diaverum AB（瑞典）
• Dialife SA（瑞士）
• Isopure 公司（美國）
• 羅克韋爾醫療公司（美國）
• 貝克頓迪金森公司（美國）
• JMS有限公司（日本）
• 奧美醫療用品有限公司 (中國)
• 大西洋生物醫學（美國）
• 血管動力學（美國）
• Amecath (Egypt)
• 庫克（美國）
• 醫療元件公司（美國）
• 綜合醫學（印度）
• 賽萊默（美國）
• Outset Medical, Inc.（美國）

Global Hemodialysis and Peritoneal Dialysis Market size was valued at USD 81.11 billion in 2022 and is poised to grow from USD 86.38 billion in 2023 to USD 142.97 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global hemodialysis and peritoneal dialysis market is experiencing significant growth, driven by a shortage of organ donors, the rising prevalence of acute kidney injury, and the associated risks of organ transplants. Additionally, technological advancements and innovations from leading market players are fueling the development of new products and services. Chronic kidney disease (CKD), often leading to End-Stage Renal Disease (ESRD), is a major driver of this demand, with kidney function decline linked to conditions like diabetes and hypertension. The growing incidence of diabetes, particularly due to aging, obesity, and poor lifestyle choices, is contributing to diabetic nephropathy and renal damage, further accelerating the demand for dialysis treatments globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemodialysis and Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemodialysis and Peritoneal Dialysis Market Segmental Analysis

Global Hemodialysis and Peritoneal Dialysis Market is segmented on the type, product, end use, and region. By type, Market is segmented into Hemodialysis, and Peritoneal Dialysis. By product, Market is segmented into Device, Consumables, and Service. By end use, Market is segmented into Home-based, and Hospital-based. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Hemodialysis and Peritoneal Dialysis Market

The rising awareness campaigns surrounding kidney diseases and the availability of treatment options are driving early diagnosis and intervention, thereby expanding the patient base for dialysis therapies. Global initiatives such as World Kidney Day have played a key role in raising awareness about kidney health, encouraging regular screenings. This focus on early detection enables timely interventions, which are crucial for effective treatment. As more people undergo screenings and seek care at earlier stages, the demand for dialysis treatments, including hemodialysis and peritoneal dialysis, is growing. These efforts are contributing significantly to the market's expansion by addressing the increasing need for dialysis solutions worldwide.

Restraints in the Global Hemodialysis and Peritoneal Dialysis Market

The high costs associated with hemodialysis treatment, including equipment, consumables, and facility fees, present a significant challenge to the growth of the global Hemodialysis and Peritoneal Dialysis market. In low- and middle-income countries, the financial burden of accessing proper treatment becomes even more pronounced due to the high expense of necessary equipment. Additionally, reimbursement issues and limited insurance coverage exacerbate these challenges, making it difficult for many patients to afford consistent care. These financial constraints limit the accessibility of treatment options and hinder the overall expansion of the market.

Market Trends of the Global Hemodialysis and Peritoneal Dialysis Market

The global Hemodialysis and Peritoneal Dialysis market is experiencing significant growth driven by the rising prevalence of chronic kidney disease (CKD), improved healthcare infrastructure, and expanded access to renal replacement therapies. Emerging markets present substantial growth opportunities, as these regions see a surge in demand for affordable, localized dialysis solutions. Companies can leverage this growth potential by entering developing economies with cost-effective offerings tailored to meet the specific needs of these markets. This trend highlights the vast potential for expansion, as the demand for dialysis treatments continues to rise globally.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Value Chain Analysis
• Supply Chain Analysis
• Technology Analysis
• Patent Analysis
• Pricing Analysis
• Trade Analysis
• Customer & Buying Criteria Analysis

Hemodialysis And Peritoneal Dialysis Market, By Type

• Market Overview
• Hemodialysis
  • Conventional
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Hemodialysis And Peritoneal Dialysis Market, By Product

• Market Overview
• Device
  • Machine
  • Dialyzers
  • Water Treatment System
  • Others
• Consumables
  • Bloodlines
  • Concentrates
  • Catheters
  • Others
• Service

Hemodialysis And Peritoneal Dialysis Market, By End Use

• Market Overview
• Home-based
• Hospital-based

Hemodialysis And Peritoneal Dialysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Fresenius Medical Care AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Davita Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialife SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Isopure Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockwell Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlantic Biomedical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Components Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polymedicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xylem (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Outset Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments